Compare BCSF & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCSF | CRON |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 901.0M | 961.2M |
| IPO Year | 2018 | N/A |
| Metric | BCSF | CRON |
|---|---|---|
| Price | $14.36 | $3.06 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | 397.4K | ★ 2.7M |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | ★ 12.41% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.44 | 0.09 |
| Revenue | ★ $278,347,000.00 | $132,357,000.00 |
| Revenue This Year | N/A | $19.67 |
| Revenue Next Year | N/A | $30.56 |
| P/E Ratio | ★ $10.08 | $34.73 |
| Revenue Growth | N/A | ★ 19.00 |
| 52 Week Low | $13.20 | $1.60 |
| 52 Week High | $19.21 | $3.29 |
| Indicator | BCSF | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 53.42 | 68.77 |
| Support Level | $14.31 | $2.40 |
| Resistance Level | $14.68 | $2.92 |
| Average True Range (ATR) | 0.20 | 0.17 |
| MACD | 0.02 | 0.08 |
| Stochastic Oscillator | 56.96 | 63.59 |
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.